期刊文献+

临床药师在系统性硬化症诊断中的作用

Role of Clinical Pharmacist in Systemic Sclerosis Diagnosis
下载PDF
导出
摘要 目的探讨临床药师在系统性硬化症诊断中的作用。方法临床药师通过临床药学监护及药学问诊,发现问题并及时与临床医师沟通,使患者的其他疾病体征得到重视。结果两例多年误诊为其他疾病的系统性硬化症患者得到确诊。结论临床药师充分发挥优势,与临床医师有效合作,可以成为治疗团队不可缺少的一部分。 Objective To discuss the role of of clinical pharmacist in systemic sclerosis diagnosis. Methods Clinical pharmacist discovered the problem through pharmaceutical care and pharmacy interrogation, and communicated with the clinical doctors, other symptoms of patient were considered. Results Two cases which were misdiagnosed many years got diagnosis correctly. Conclusion Clinical pharmacist can be an indispensable part of the treatment team through giving the full their advantage and cooperating with doctors efficiently.
出处 《山西大同大学学报(自然科学版)》 2015年第2期36-37,42,共3页 Journal of Shanxi Datong University(Natural Science Edition)
关键词 系统性硬化症 误诊 临床药师 systemic sclerosis misdiagnosis clinical pharmacist
  • 相关文献

参考文献10

二级参考文献53

  • 1崔炳南,李理.色素性痒疹[J].临床皮肤科杂志,2006,35(8):537-537. 被引量:5
  • 2Reveille JD, Solomon DH. Evidence-based guidelines for the useof immunologic tests: anticentromere, Scl-70, and nucleolar anti-bodies. Arthritis Rheum, 2003, 49( 3 ): 399-412.
  • 3Ho KT, Reveille JD. The clinical relevance of autoantibodies inscleroderma. Arthritis Res Ther, 2003, 5 (2): 80-93.
  • 4Okano Y. Antinuclear antibody in systemic sclerosis (sclero-derma). Rheum Dis Clin North Am, 1996, 22(4): 709-735.
  • 5Steen VD. Autoantibodies in systemic sclerosis. Semin ArthritisRheum, 2005, 35( 1 ): 35-42.
  • 6Prehminary criteria for the classificatlon ot systemic sclerosis(scleroderma). Subcommittee for scleroderma criteria of theAmerican Rheumatism Association Diagnostic and TherapeuticCriteria Committee. Arthritis Rheum, 1980, 23(5 ): 581-590.
  • 7Leroy EC, Black C, Fleischmajer R, et al. Scleroderma (systemicsclerosis): classification, subsets and pathogenesis. J Rheumatol,1988, 15(2): 202-205.
  • 8Reveille JD, Fischbach M, Mcnearney T, et al. Systemic sclerosisin 3 US ethnic groups: a comparison of clinical, sociodemo-graphic, serologic, and immunogenetic determinants. SeminArthritis Rheum, 2001, 30(5 ): 332-346.
  • 9Hamaguchi Y, Hasegawa M, Fujimoto M, et al. The clinical rele-vance of serum antinuclear antibodies in Japanese patients withsystemic sclerosis. Br J Dermatol, 2008, 158(3 ): 487-495.
  • 10Makol A,Petri M.Pancreatitis in systemic lupus erythematosus:frequency and associated factors-a review of the Hopkins Lupus Cohort.J Rheumatol,2010,37(2):341-345.

共引文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部